FBR Still Impressed with CVS Health (CVS) Following Inline Q4 Results; Affirms at 'Outperform'

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. TSLA
6. META
7. RTX
8. SMCI
9. GOOGL
10. S

Go back to FBR Still Impressed with CVS Health (CVS) Following Inline Q4 Results; Affirms at 'Outperform'

CVS Health (CVS) Reports In-Line Q4 EPS

February 9, 2016 6:52 AM EST

CVS Health (NYSE: CVS) reported Q4 EPS of $1.53, in-line with the analyst estimate of $1.53. Revenue for the quarter came in at $41.15 billion versus the consensus estimate of $41.13 billion.

Revenues in the Pharmacy Services Segment increased 11.1% to $26.5 billion in the three months ended December 31, 2015. This increase was primarily driven by growth in specialty pharmacy, which includes the impact of the Omnicare, Inc. ("Omnicare") acquisition in August 2015, and pharmacy network claims. Pharmacy network claims processed during the three months ended December 31, 2015, increased 7.2% to 237.4 million, compared to 221.6 million in the... More